# Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine

> **NCT01084291** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 18 (actual)

## Conditions studied

- Dengue Virus

## Interventions

- **BIOLOGICAL:** Investigational Vaccine for DEN1
- **OTHER:** Placebo injection

## Key facts

- **NCT ID:** NCT01084291
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084291, "Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01084291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*